drugset / Trial / NCT01386970

Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

NCT01386970

Non-randomizedParallel-groupOpen-labelOther

Summary

This study evaluated the blood and blood cell concentrations of zidovudine and lamivudine in men versus women and in those with versus without HIV infection. Additionally, markers of side effects were correlated with blood levels of the drugs. The hypothesis was that women and those with HIV would have higher drug levels, as well as markers of side effects.

Timeline

Start
2005-05
Primary completion
2008-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lamivudine Other / unclassified 150 mg
Comparator Zidovudine Small molecule 300 mg